Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pGL3-FLIP1500 Citations (3)

Originally described in: Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity.
Ricci MS, Jin Z, Dews M, Yu D, Thomas-Tikhonenko A, Dicker DT, El-Deiry WS Mol Cell Biol. 2004 Oct . 24(19):8541-55.
PubMed Journal

Articles Citing pGL3-FLIP1500

Articles
Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells. Siegelin MD, Dohi T, Raskett CM, Orlowski GM, Powers CM, Gilbert CA, Ross AH, Plescia J, Altieri DC. J Clin Invest. 2011 Apr;121(4):1349-60. doi: 10.1172/JCI44855. PubMed
Cordycepin promotes apoptosis in renal carcinoma cells by activating the MKK7-JNK signaling pathway through inhibition of c-FLIPL expression. Hwang IH, Oh SY, Jang HJ, Jo E, Joo JC, Lee KB, Yoo HS, Lee MY, Park SJ, Jang IS. PLoS One. 2017 Oct 18;12(10):e0186489. doi: 10.1371/journal.pone.0186489. eCollection 2017. PubMed
GZ17-6.02 Interacts With [MEK1/2 and B-RAF Inhibitors] to Kill Melanoma Cells. Booth L, West C, Von Hoff D, Kirkwood JM, Dent P. Front Oncol. 2021 Apr 8;11:656453. doi: 10.3389/fonc.2021.656453. eCollection 2021. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.